Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Disease Progression and JAK1[original query] |
|---|
| Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1. Genome medicine 2017 May 9 (1): 46. Sveen Anita, Johannessen Bjarne, Tengs Torstein, Danielsen Stine A, Eilertsen Ina A, Lind Guro E, Berg Kaja C G, Leithe Edward, Meza-Zepeda Leonardo A, Domingo Enric, Myklebost Ola, Kerr David, Tomlinson Ian, Nesbakken Arild, Skotheim Rolf I, Lothe Ragnhild |
| A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs. Lung cancer (Amsterdam, Netherlands) 2019 7 134 46-51. Park Ji Soo, Hong Min Hee, Chun You Jin, Kim Hye Ryun, Cho Byoung Ch |
| Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 12 38 (10): 1006-1018. Dao Kim-Hien T, Gotlib Jason, Deininger Michael M N, Oh Stephen T, Cortes Jorge E, Collins Robert H, Winton Elliot F, Parker Dana R, Lee Hyunjung, Reister Anna, Schultz , Savage Samantha, Stevens , Brockett Chase, Subbiah Nan, Press Richard D, Raess Philipp W, Cascio Michael, Dunlap Jennifer, Chen Yiyi, Degnin Catherine, Maxson Julia E, Tognon Cristina E, Macey Tara, Druker Brian J, Tyner Jeffrey |
- Page last reviewed:Feb 1, 2024
- Content source: